Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis

NCT00269867 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

428

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Placebo
DRUG: Infliximab 3 mg/kg
DRUG: Infliximab 10 mg/kg

Sponsor

Centocor, Inc.